|
UBFD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.72359999945004E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.594220E-02 |
| Normal-vs-Stage2 |
4.840000E-02 |
| Normal-vs-Stage3 |
3.637900E-03 |
| Normal-vs-Stage4 |
8.888200E-02 |
| Stage1-vs-Stage2 |
2.641000E-01 |
| Stage1-vs-Stage3 |
2.878400E-02 |
| Stage1-vs-Stage4 |
1.978430E-01 |
| Stage2-vs-Stage3 |
2.785400E-01 |
| Stage2-vs-Stage4 |
3.807000E-01 |
| Stage3-vs-Stage4 |
9.845800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.2569999997587E-07 |
| Normal-vs-AfricanAmerican |
9.848000E-02 |
| Normal-vs-Asian |
5.489200E-01 |
| Caucasian-vs-AfricanAmerican |
1.041990E-01 |
| Caucasian-vs-Asian |
6.414800E-01 |
| AfricanAmerican-vs-Asian |
9.187000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.40950000000618E-05 |
| Normal-vs-Female |
3.522899999997E-05 |
| Male-vs-Female |
5.074000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.375000E-01 |
| Normal-vs-Extreme_Weight |
6.879800E-02 |
| Normal-vs-Obese |
6.17290000000104E-05 |
| Normal-vs-Extreme_Obese |
3.707200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.669400E-01 |
| Normal_Weight-vs-Obese |
5.170400E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.171200E-01 |
| Extreme_Weight-vs-Obese |
1.488070E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.781600E-01 |
| Obese-vs-Extreme_Obese |
4.424200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.538500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.42490000001983E-06 |
| Normal-vs-Age(61-80Yrs) |
3.704500E-03 |
| Normal-vs-Age(81-100Yrs) |
8.557400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.908000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.335700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.559900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.129400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.816100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.061170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.221330E-04 |
| Normal-VS-Type2 PRCC |
1.848210E-02 |
| Normal-VS-KIRP CIMP |
4.663000E-03 |
| Normal-VS-Unclassified PRCC |
3.756100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.030200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.69740000000629E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.365900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.064160E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.090100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.812000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.025170E-01 |
| Normal-vs-N1 |
6.427800E-04 |
| Normal-vs-N2 |
2.444200E-01 |
| N0-vs-N1 |
2.603300E-03 |
| N0-vs-N2 |
3.144200E-01 |
| N1-vs-N2 |
5.840600E-01 |
|
|
